Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia

被引:156
|
作者
Berridge, Michael J. [1 ]
机构
[1] Babraham Inst, Cambridge, England
关键词
calcium; inositol trisphosphate; Alzheimer disease; schizophrenia; bipolar disease; reactive oxygen species; D-RECEPTOR GENE; VITAMIN-D; UP-REGULATION; MOUSE MODEL; PC12; CELLS; CA2+; LITHIUM; RELEASE; HOMEOSTASIS; ACTIVATION;
D O I
10.4161/pri.21767
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurons have highly developed Ca2+ signaling systems responsible for regulating a large number of neural functions such as the control of brain rhythms, information processing and the changes in synaptic plasticity that underpin learning and memory. The tonic excitatory drive, which is activated by the ascending arousal system, is particularly important for processes such as sensory perception, cognition and consciousness. The Ca2+ signaling pathway is a key component of this arousal system that regulates the neuronal excitability responsible for controlling the neural brain rhythms required for information processing and cognition. Dysregulation of the Ca2+ signaling pathway responsible for many of these neuronal processes has been implicated in the development of some of the major neural diseases in man such as Alzheimer disease, bipolar disorder and schizophrenia. Various treatments, which are known to act by reducing the activity of Ca2+ signaling, have proved successful in alleviating the symptoms of some of these neural diseases.
引用
收藏
页码:2 / 13
页数:12
相关论文
共 50 条
  • [1] Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease
    Popugaeva, Elena
    Pchitskaya, Ekaterina
    Bezprozvanny, Ilya
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2018, 29 (12) : 1176 - 1188
  • [2] Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia
    Berridge, Michael J.
    [J]. CELL AND TISSUE RESEARCH, 2014, 357 (02) : 477 - 492
  • [3] Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia
    Michael J. Berridge
    [J]. Cell and Tissue Research, 2014, 357 : 477 - 492
  • [4] Role of GPCR signaling and calcium dysregulation in Alzheimer's disease
    Sushma
    Mondal, Amal Chandra
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 101
  • [5] Overlapping gene dysregulation in schizophrenia and bipolar disorder
    Glatt, Stephen J.
    Everall, Ian R.
    Kanazawa, Tetsufumi
    Chana, Gursharan
    Tsuang, Ming T.
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 16S - 16S
  • [6] Epigenetic age dysregulation in individuals with bipolar disorder and schizophrenia
    Jeremian, Richie
    Malinowski, Alexandra
    Chaudhary, Zanib
    Srivastava, Anil
    Qian, Jessica
    Zai, Clement
    Adanty, Christopher
    Fischer, Corinne E.
    Burhan, Amer M.
    Kennedy, James L.
    Borlido, Carol
    Gerretsen, Philip
    Graff, Ariel
    Remington, Gary
    Vincent, John B.
    Strauss, John S.
    De Luca, Vincenzo
    [J]. PSYCHIATRY RESEARCH, 2022, 315
  • [7] Dysregulation of calcium in Alzheimer's disease
    Brzyska, M
    Elbaum, D
    [J]. ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2003, 63 (03) : 171 - 183
  • [8] The dysregulation of intracellular calcium in Alzheimer disease
    Supnet, Charlene
    Bezprozvanny, Ilya
    [J]. CELL CALCIUM, 2010, 47 (02) : 183 - 189
  • [9] Calcium dysregulation in Alzheimer's disease
    Bojarski, Lukasz
    Herms, Jochen
    Kuznicki, Jacek
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (4-5) : 621 - 633
  • [10] Disease specific brain capillary angiopathy in schizophrenia, bipolar disorder, and Alzheimer's disease
    Hirai, Shinobu
    Sakuma, Atsuhiro
    Kunii, Yasuto
    Shimbo, Hiroko
    Hino, Mizuki
    Izumi, Ryuta
    Nagaoka, Atsuko
    Yabe, Hirooki
    Kojima, Rika
    Seki, Erika
    Arai, Nobutaka
    Komori, Takashi
    Okado, Haruo
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 163 : 74 - 79